Concourse Financial Group Securities’s Abiomed Inc ABMD Stock Holding History

Concourse Financial Group Securities’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,324	Closed	-$628K	–	2342
2022 Q2	$575K	Sell	2,324 -93	-4%	-$25.1K	0.05%	368
2022 Q1	$801K	Buy	2,417 +2,371	+5,154%	+$730K	0.06%	321
2021 Q4	$17K	Hold	46	–	–	﹤0.01%	1711
2021 Q3	$15K	Hold	46	–	–	﹤0.01%	1760
2021 Q2	$14K	Hold	46	–	–	﹤0.01%	1770
2021 Q1	$15K	Sell	46 -18	-28%	-$5.76K	﹤0.01%	1659
2020 Q4	$21K	Hold	64	–	–	﹤0.01%	1452
2020 Q3	$18K	Hold	64	–	–	﹤0.01%	1407
2020 Q2	$15K	Sell	64 -68	-52%	-$13.7K	﹤0.01%	1403
2020 Q1	$19K	Buy	+132	New	+$21.9K	﹤0.01%	1263
2019 Q2	–	Sell	-94	Closed	-$24.9K	–	2441
2019 Q1	$26K	Sell	94 -48	-34%	-$16K	﹤0.01%	1158
2018 Q4	$46K	Sell	142 -25	-15%	-$8.68K	0.01%	847
2018 Q3	$75K	Buy	+167	New	+$65.8K	0.02%	496

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Concourse Financial Group Securities's ABMD Position: Q3 2022 in Review

Concourse Financial Group Securities sold out of Abiomed Inc (ABMD) in Q3 2022, closing a stake of 2,324 shares — an estimated $628K sold.

Concourse Financial Group Securities first reported a position in ABMD in Q3 2018 and held it in 13 quarters. The position peaked at $801K in Q1 2022. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

Concourse Financial Group Securities reported no remaining Abiomed Inc position as of Q3 2022 after selling out during the quarter.
Concourse Financial Group Securities sold 2,324 Abiomed Inc shares in Q3 2022, an estimated $628K.
Concourse Financial Group Securities first reported a position in Abiomed Inc in Q3 2018 and held it in 13 quarters.
Concourse Financial Group Securities's Abiomed Inc position peaked at $801K in Q1 2022.
517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on Concourse Financial Group Securities's 13F filing for Q3 2022, filed 15 Nov 2022.